Viewing Study NCT01770795


Ignite Creation Date: 2025-12-24 @ 1:40 PM
Ignite Modification Date: 2026-04-13 @ 4:50 PM
Study NCT ID: NCT01770795
Status: COMPLETED
Last Update Posted: 2013-01-18
First Post: 2013-01-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer
Sponsor: Gachon University Gil Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2011-GIRBA-2351
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators